/**
 * Copyright 2015 Canada Health Infoway, Inc.
 *
 * Licensed under the Apache License, Version 2.0 (the "License");
 * you may not use this file except in compliance with the License.
 * You may obtain a copy of the License at
 *
 *        http://www.apache.org/licenses/LICENSE-2.0
 *
 * Unless required by applicable law or agreed to in writing, software
 * distributed under the License is distributed on an "AS IS" BASIS,
 * WITHOUT WARRANTIES OR CONDITIONS OF ANY KIND, either express or implied.
 * See the License for the specific language governing permissions and
 * limitations under the License.
 *
 * Author:        $LastChangedBy: tmcgrady $
 * Last modified: $LastChangedDate: 2011-05-04 15:47:15 -0400 (Wed, 04 May 2011) $
 * Revision:      $LastChangedRevision: 2623 $
 */
/* This class was auto-generated by the message builder generator tools. */
namespace Ca.Infoway.Messagebuilder.Model.Pcs_cerx_v01_r04_4.Pharmacy.Merged {
    using Ca.Infoway.Messagebuilder.Annotation;
    using Ca.Infoway.Messagebuilder.Datatype;
    using Ca.Infoway.Messagebuilder.Datatype.Impl;
    using Ca.Infoway.Messagebuilder.Model;
    using Ca.Infoway.Messagebuilder.Model.Pcs_cerx_v01_r04_4.Pharmacy.Porx_mt980050ca;
    using System;


    /**
     * <summary>PORX_MT060060CA.Reason: d:prescribed because of</summary>
     * 
     * <p>Helps providers evaluate the appropriateness of the usage 
     * instructions for the device, and may influence education or 
     * literature provided to the patient on the use of the 
     * device.</p><p>Provided at the discretion of the prescriber 
     * to enhance patient care.</p><p>This field is marked as 
     * populated because of its high clinical importance, however 
     * 'Nulls' are allowed because the individual recording the 
     * prescription (e.g. pharmacist) may not be aware of the 
     * indication or the prescriber may choose to withhold (mask) 
     * the information due to patient sensitivity.</p> <p>Denotes 
     * the reason(s) for this specific prescription; it must not be 
     * interpreted as a permanent diagnosis.</p> 
     * PORX_MT010120CA.Reason2: *d:has prescribing reasons <p>Helps 
     * providers evaluate the appropriateness of the dosage 
     * instructions for the medication, and may influence education 
     * or literature provided to the patient on the use of the 
     * medication.</p><p>Provided at the discretion of the 
     * prescriber to enhance patient care. E.g., take 1 tab bid for 
     * migraine. Also needed for drug-disease interaction checking 
     * software to work properly.</p><p>This field is marked as 
     * populated because of its high clinical importance, however 
     * 'Nulls' are allowed because the individual recording the 
     * prescription (e.g. pharmacist) may not be aware of the 
     * indication or the prescriber may choose to withhold (mask) 
     * the information due to patient sensitivity.</p> <p>Denotes 
     * the reason(s) for this specific prescription; it must not be 
     * interpreted as a permanent diagnosis.</p> 
     * PORX_MT060340CA.Reason2: d:prescribed because of <p>Helps 
     * providers evaluate the appropriateness of the dosage 
     * instructions for the medication, and may influence education 
     * or literature provided to the patient on the use of the 
     * medication.</p><p>Provided at the discretion of the 
     * prescriber to enhance patient care. E.g., take 1 tab bid for 
     * migraine. Also needed for drug-disease interaction checking 
     * software to work properly.</p><p>This field is marked as 
     * populated because of its high clinical importance, however 
     * 'Nulls' are allowed because the individual recording the 
     * prescription (e.g. pharmacist) may not be aware of the 
     * indication or the prescriber may choose to withhold (mask) 
     * the information due to patient sensitivity.</p> <p>Denotes 
     * the reason(s) for this specific prescription; it must not be 
     * interpreted as a permanent diagnosis.</p> 
     * PORX_MT030040CA.Reason: d:prescribed because of <p>Helps 
     * providers evaluate the appropriateness of the dosage 
     * instructions for the medication, and may influence education 
     * or literature provided to the patient on the use of the 
     * medication.</p><p>Provided at the discretion of the 
     * prescriber to enhance patient care. E.g., take 1 tab bid for 
     * migraine. Also needed for drug-disease interaction checking 
     * software to work properly.</p><p>This field is marked as 
     * populated because of its high clinical importance, however 
     * 'Nulls' are allowed because the individual recording the 
     * prescription (e.g. pharmacist) may not be aware of the 
     * indication or the prescriber may choose to withhold (mask) 
     * the information due to patient sensitivity.</p> <p>Denotes 
     * the reason(s) for this specific prescription; it must not be 
     * interpreted as a permanent diagnosis.</p> 
     * PORX_MT060040CA.Reason2: d:prescribed because of <p>Helps 
     * providers evaluate the appropriateness of the instructions 
     * for the device, and may influence education or literature 
     * provided to the patient on the use of the 
     * device.</p><p>Provided at the discretion of the prescriber 
     * to enhance patient care. E.g., take 1 tab bid for migraine. 
     * Also needed for drug-disease interaction checking software 
     * to work properly.</p><p>This field is marked as populated 
     * because of its high clinical importance, however 'Nulls' are 
     * allowed because the individual recording the prescription 
     * (e.g. pharmacist) may not be aware of the indication or the 
     * prescriber may choose to withhold (mask) the information due 
     * to patient sensitivity.</p> <p>Denotes the reason(s) for 
     * this specific prescription; it must not be interpreted as a 
     * permanent diagnosis.</p> PORX_MT060190CA.Reason: 
     * d:prescribed because of <p>Helps providers evaluate the 
     * appropriateness of the dosage instructions for the 
     * medication, and may influence education or literature 
     * provided to the patient on the use of the 
     * medication.</p><p>Provided at the discretion of the 
     * prescriber to enhance patient care. E.g., take 1 tab bid for 
     * migraine. Also needed for drug-disease interaction checking 
     * software to work properly.</p><p>This field is marked as 
     * populated because of its high clinical importance, however 
     * 'Nulls' are allowed because the individual recording the 
     * prescription (e.g. pharmacist) may not be aware of the 
     * indication or the prescriber may choose to withhold (mask) 
     * the information due to patient sensitivity.</p> <p>Denotes 
     * the reason(s) for this specific prescription; it must not be 
     * interpreted as a permanent diagnosis.</p> 
     * PORX_MT060160CA.Reason2: d:prescribed because of <p>Helps 
     * providers evaluate the appropriateness of the dosage 
     * instructions for the medication, and may influence education 
     * or literature provided to the patient on the use of the 
     * medication.</p><p>Provided at the discretion of the 
     * prescriber to enhance patient care. E.g., take 1 tab bid for 
     * migraine. Also needed for drug-disease interaction checking 
     * software to work properly.</p><p>This field is marked as 
     * populated because of its high clinical importance, however 
     * 'Nulls' are allowed because the individual recording the 
     * prescription (e.g. pharmacist) may not be aware of the 
     * indication or the prescriber may choose to withhold (mask) 
     * the information due to patient sensitivity.</p> <p>Denotes 
     * the reason(s) for this specific prescription; it must not be 
     * interpreted as a permanent diagnosis.</p> 
     * PORX_MT010110CA.Reason2: *d:has prescribing reasons <p>Helps 
     * providers evaluate the appropriateness of the instructions 
     * for the device, and may influence education or literature 
     * provided to the patient on the use of the 
     * device.</p><p>Provided at the discretion of the prescriber 
     * to enhance patient care.</p><p>This field is marked as 
     * populated because of its high clinical importance, however 
     * 'Nulls' are allowed because the individual recording the 
     * prescription (e.g. pharmacist) may not be aware of the 
     * indication or the prescriber may choose to withhold (mask) 
     * the information due to patient sensitivity.</p> <p>Denotes 
     * the reason(s) for this specific prescription; it must not be 
     * interpreted as a permanent diagnosis.</p>
     */
    [Hl7PartTypeMappingAttribute(new string[] {"PORX_MT010110CA.Reason2","PORX_MT010120CA.Reason2","PORX_MT030040CA.Reason","PORX_MT060040CA.Reason2","PORX_MT060060CA.Reason","PORX_MT060160CA.Reason2","PORX_MT060190CA.Reason","PORX_MT060340CA.Reason2"})]
    public class PrescribedBecauseOf : MessagePartBean {

        private INT priorityNumber;
        private Ca.Infoway.Messagebuilder.Model.Pcs_cerx_v01_r04_4.Pharmacy.Porx_mt980050ca.IIndications indications;

        public PrescribedBecauseOf() {
            this.priorityNumber = new INTImpl();
        }
        /**
         * <summary>Business Name: IndicationPriority</summary>
         * 
         * <remarks>Un-merged Business Name: IndicationPriority 
         * Relationship: PORX_MT060060CA.Reason.priorityNumber 
         * Conformance/Cardinality: REQUIRED (0-1) <p>Allows providers 
         * to indicate whether indication is the primary or secondary 
         * target of the therapy. E.g., Terazosin for Benign Prostatic 
         * Hypertrophy as primary and Hypertension as secondary or 
         * vice-versa.</p> <p>Ordering of prescribing indications from 
         * primary indication (low number) to minor indication (higher 
         * number). Multiple indications are permitted to have the same 
         * priority if they're considered of equivalent importance.</p> 
         * Un-merged Business Name: IndicationPriority Relationship: 
         * PORX_MT010120CA.Reason2.priorityNumber 
         * Conformance/Cardinality: REQUIRED (0-1) <p>Allows providers 
         * to indicate whether indication is the primary or secondary 
         * target of the therapy. E.g., Terazosin for Benign Prostatic 
         * Hypertrophy as primary and Hypertension as secondary or 
         * vice-versa.</p> <p>Ordering of prescribing indications from 
         * primary indication (low number) to minor indication (higher 
         * number). Multiple indications are permitted to have the same 
         * priority if they're considered of equivalent importance.</p> 
         * Un-merged Business Name: IndicationPriority Relationship: 
         * PORX_MT030040CA.Reason.priorityNumber 
         * Conformance/Cardinality: REQUIRED (0-1) <p>Allows providers 
         * to indicate whether indication is the primary or secondary 
         * target of the therapy. E.g., Terazosin for Benign Prostatic 
         * Hypertrophy as primary and Hypertension as secondary or 
         * vice-versa.</p> <p>Ordering of prescribing indications from 
         * primary indication (low number) to minor indication (higher 
         * number). Multiple indications are permitted to have the same 
         * priority if they're considered of equivalent importance.</p> 
         * Un-merged Business Name: IndicationPriority Relationship: 
         * PORX_MT060340CA.Reason2.priorityNumber 
         * Conformance/Cardinality: REQUIRED (0-1) <p>Allows providers 
         * to indicate whether indication is the primary or secondary 
         * target of the therapy. E.g., Terazosin for Benign Prostatic 
         * Hypertrophy as primary and Hypertension as secondary or 
         * vice-versa.</p> <p>Ordering of prescribing indications from 
         * primary indication (low number) to minor indication (higher 
         * number). Multiple indications are permitted to have the same 
         * priority if they're considered of equivalent importance.</p> 
         * Un-merged Business Name: IndicationPriority Relationship: 
         * PORX_MT060040CA.Reason2.priorityNumber 
         * Conformance/Cardinality: REQUIRED (0-1) <p>Allows providers 
         * to indicate whether indication is the primary or secondary 
         * target of the therapy. E.g., Terazosin for Benign Prostatic 
         * Hypertrophy as primary and Hypertension as secondary or 
         * vice-versa.</p> <p>Ordering of prescribing indications from 
         * primary indication (low number) to minor indication (higher 
         * number). Multiple indications are permitted to have the same 
         * priority if they're considered of equivalent importance.</p> 
         * Un-merged Business Name: IndicationPriority Relationship: 
         * PORX_MT060160CA.Reason2.priorityNumber 
         * Conformance/Cardinality: REQUIRED (0-1) <p>Allows providers 
         * to indicate whether indication is the primary or secondary 
         * target of the therapy. E.g., Terazosin for Benign Prostatic 
         * Hypertrophy as primary and Hypertension as secondary or 
         * vice-versa.</p> <p>Ordering of prescribing indications from 
         * primary indication (low number) to minor indication (higher 
         * number). Multiple indications are permitted to have the same 
         * priority if they're considered of equivalent importance.</p> 
         * Un-merged Business Name: IndicationPriority Relationship: 
         * PORX_MT060190CA.Reason.priorityNumber 
         * Conformance/Cardinality: REQUIRED (0-1) <p>Allows providers 
         * to indicate whether indication is the primary or secondary 
         * target of the therapy. E.g., Terazosin for Benign Prostatic 
         * Hypertrophy as primary and Hypertension as secondary or 
         * vice-versa.</p> <p>Ordering of prescribing indications from 
         * primary indication (low number) to minor indication (higher 
         * number). Multiple indications are permitted to have the same 
         * priority if they're considered of equivalent importance.</p> 
         * Un-merged Business Name: IndicationPriority Relationship: 
         * PORX_MT010110CA.Reason2.priorityNumber 
         * Conformance/Cardinality: REQUIRED (0-1) <p>Allows providers 
         * to indicate whether indication is the primary or secondary 
         * target of the therapy. E.g., Terazosin for Benign Prostatic 
         * Hypertrophy as primary and Hypertension as secondary or 
         * vice-versa.</p> <p>Ordering of prescribing indications from 
         * primary indication (low number) to minor indication (higher 
         * number). Multiple indications are permitted to have the same 
         * priority if they're considered of equivalent importance.</p></remarks>
         */
        [Hl7XmlMappingAttribute(new string[] {"priorityNumber"})]
        public int? PriorityNumber {
            get { return this.priorityNumber.Value; }
            set { this.priorityNumber.Value = value; }
        }

        /**
         * <summary>Un-merged Business Name: (no business name 
         * specified)</summary>
         * 
         * <remarks>Relationship: PORX_MT060060CA.Reason.indications 
         * Conformance/Cardinality: REQUIRED (1) Un-merged Business 
         * Name: (no business name specified) Relationship: 
         * PORX_MT010120CA.Reason2.indications Conformance/Cardinality: 
         * REQUIRED (1) Un-merged Business Name: (no business name 
         * specified) Relationship: PORX_MT030040CA.Reason.indications 
         * Conformance/Cardinality: REQUIRED (1) Un-merged Business 
         * Name: (no business name specified) Relationship: 
         * PORX_MT060340CA.Reason2.indications Conformance/Cardinality: 
         * REQUIRED (1) Un-merged Business Name: (no business name 
         * specified) Relationship: PORX_MT060040CA.Reason2.indications 
         * Conformance/Cardinality: REQUIRED (1) Un-merged Business 
         * Name: (no business name specified) Relationship: 
         * PORX_MT060160CA.Reason2.indications Conformance/Cardinality: 
         * REQUIRED (1) Un-merged Business Name: (no business name 
         * specified) Relationship: PORX_MT060190CA.Reason.indications 
         * Conformance/Cardinality: REQUIRED (1) Un-merged Business 
         * Name: (no business name specified) Relationship: 
         * PORX_MT010110CA.Reason2.indications Conformance/Cardinality: 
         * REQUIRED (1)</remarks>
         */
        [Hl7XmlMappingAttribute(new string[] {"indications"})]
        public Ca.Infoway.Messagebuilder.Model.Pcs_cerx_v01_r04_4.Pharmacy.Porx_mt980050ca.IIndications Indications {
            get { return this.indications; }
            set { this.indications = value; }
        }

    }

}